These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1310746)

  • 21. Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2.
    Tzeng JJ; Barth RF; Clendenon NR; Gordon WA
    Cancer Res; 1990 Jul; 50(14):4338-43. PubMed ID: 2364388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma and natural killer cells: studies in a novel rat model in vitro and in vivo.
    Winter BK; Wu S; Nelson AC; Pollack SB
    Cancer Res; 1992 Nov; 52(22):6279-86. PubMed ID: 1423274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
    Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
    Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.
    Pesic M; Markovic JZ; Jankovic D; Kanazir S; Markovic ID; Rakic L; Ruzdijic S
    J Chemother; 2006 Feb; 18(1):66-73. PubMed ID: 16572896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of an orthotopic model of human lung cancer with regional and systemic metastases.
    Johnston MR; Mullen JB; Pagura ME; Howard RB
    Ann Thorac Surg; 2001 Apr; 71(4):1120-5. PubMed ID: 11308147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanoma.
    Gautam SC; Chikkala NF; Lewis I; Grabowski DR; Finke JH; Ganapathi R
    Anticancer Res; 1992; 12(3):921-5. PubMed ID: 1622150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-glycoprotein modulation by valspodar and cyclosporin does not increase tumor uptake of doxorubicin administered via isolated lung perfusion to rats bearing sarcoma lung metastases.
    Kuemmerle A; Yan H; Krueger T; Buclin T; Braissant O; Henry H; Ris HB; Decosterd LA
    Anticancer Res; 2011 Jun; 31(6):2121-8. PubMed ID: 21737631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a small cell lung cancer variant resistant to lymphokine-activated killer (LAK) cells: association with resistance to a LAK cell-derived, cytostatic factor.
    Tachibana I; Watanabe M; Tanio Y; Hayashi S; Hosoe S; Saito S; Matsunashi M; Osaki T; Shigedo Y; Masuno T
    Cancer Res; 1992 Jun; 52(12):3310-6. PubMed ID: 1350752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.
    McLemore TL; Liu MC; Blacker PC; Gregg M; Alley MC; Abbott BJ; Shoemaker RH; Bohlman ME; Litterst CC; Hubbard WC
    Cancer Res; 1987 Oct; 47(19):5132-40. PubMed ID: 3621199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo.
    Minchin RF; Johnston MR; Aiken MA; Boyd MR
    J Pharmacol Exp Ther; 1984 Apr; 229(1):193-8. PubMed ID: 6707934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of lymphokine-activated killer cells of head and neck tumors in vitro and in nude mice].
    Duan DS
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(5):281-3, 314. PubMed ID: 8192930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
    Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
    Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.
    Stewart JA; Belinson JL; Moore AL; Dorighi JA; Grant BW; Haugh LD; Roberts JD; Albertini RJ; Branda RF
    Cancer Res; 1990 Oct; 50(19):6302-10. PubMed ID: 2205379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytochemicals potentiate interleukin-2 generated lymphokine-activated killer cell cytotoxicity against murine renal cell carcinoma.
    Wang Y; Qian XJ; Hadley HR; Lau BH
    Mol Biother; 1992 Sep; 4(3):143-6. PubMed ID: 1445669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional chemotherapy via pulmonary artery with blood flow occlusion in a solitary tumor nodule model.
    Wang HY; Hochwald S; Ng B; Burt M
    Anticancer Res; 1996; 16(6B):3749-53. PubMed ID: 9042252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic effects of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on non-small lung cell cancer: an experimental with rats].
    Tang YM; Yang SF; Zhu B; Cui JS
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2021-5. PubMed ID: 16313792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of tetrahydropyranyl-doxorubicin and doxorubicin in rat isolated lung.
    Dumas M; Dubuet A; D'Athis P; Camus P; Escousse A
    J Pharm Pharmacol; 1992 Jan; 44(1):58-60. PubMed ID: 1350631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.